DSIP certificate of analysis explained: what to check

Last updated 2026-07-26

What is a DSIP certificate of analysis, and why does it matter?

A certificate of analysis (COA) is a lab report tied to one specific production batch of a peptide. It's supposed to answer two questions: is this actually DSIP (delta sleep-inducing peptide, the nonapeptide Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu), and how pure is it. Nothing more. For research peptides sold outside FDA-regulated drug channels, the COA is often the only quality evidence a buyer gets. There's no equivalent of a pharmacy label with guaranteed potency here. DSIP has no FDA-approved New Drug Application and is not lawfully marketed for human use in the United States under the Federal Food, Drug, and Cosmetic Act's drug approval requirements, 21 U.S.C. § 355 ^[1]. It exists in a gray zone: labeled "for research use only," bought mostly by people using it off-label. Because of that gray zone, the COA is doing a job that regulation would otherwise do. A weak or fake COA doesn't just mean sloppy paperwork. It means you genuinely don't know what's in the vial. That's the whole reason to learn to read one instead of just glancing at a purity percentage and moving on.

What should actually be on a real DSIP COA?

A complete COA has a short list of non-negotiable elements. If any of these are missing, the document is decorative, not evidence. Batch or lot number. This has to match the number printed on the vial or box you receive. If the COA has no lot number, or the lot number is generic ('Lot 001' on every batch since 2021), it's not tied to your actual product. Testing lab name and identifiers. A real third-party lab has a name, often an accreditation number, and a location. You should be able to search that lab and find it's a real, operating analytical chemistry facility, not a name that only appears on peptide COAs. Identity confirmation, usually by mass spectrometry (MS). This confirms the molecule's mass matches DSIP's expected molecular weight (roughly 849 Da for the free peptide). Purity alone doesn't prove identity; you can have a 99% pure sample of the wrong peptide. Purity by HPLC (high-performance liquid chromatography). This is usually the headline number, commonly reported in the high 90s (98% or higher is typical marketing language across the research peptide market). HPLC separates the peptide from side-products and shows what fraction of the total peak area is the target compound. Date of analysis and, ideally, an expiration or retest date. Peptides degrade. A COA from three years ago tells you nothing about a vial made last month. Method summary or reference to method. Better reports name the column, mobile phase, or standard method used, more than a final number with no methodology behind it.

How do I know if a DSIP COA is fake or copy-pasted?

The most common problem isn't outright forgery, it's reuse. A seller runs one real test on one batch, then attaches that same PDF to every batch sold afterward, sometimes for years. Signs of a recycled or fabricated COA: the lot number on the PDF doesn't match your vial; the analysis date predates when the seller says the batch was made; the document is a low-resolution scan or screenshot with no live lab contact information; the lab name doesn't return real search results, or returns results for a lab that doesn't do peptide testing; every product on the site, regardless of peptide, has suspiciously identical formatting and purity numbers (like 99.1% on everything). A legitimate independent lab will usually let you call and confirm they tested a sample under that report number. If a seller won't provide that path, or gets vague when asked, that's the actual signal, more than the purity percentage itself. FDA's compounding law defines a category of "bulk drug substances" and sets conditions under which unapproved substances can lawfully be compounded for a patient at all, conditions research-use peptide sellers generally aren't operating under, per the compounding provisions at 21 U.S.C. § 353b ^[1]. Nobody is auditing the auditors here. You're relying on the seller's word that the lab is real and the report is current.

Does a high purity percentage on the COA mean the peptide is safe?

No. Purity and safety are different questions, and this is the single most common misunderstanding buyers have. A 99% purity result means 99% of the detected material matches the target peak on that specific test. It says nothing about sterility, endotoxin levels, heavy metals, or residual solvents from synthesis. It also says nothing about whether the compound does anything useful once injected or whether it's safe at a given dose. DSIP's human evidence base is thin. Most of what's known comes from small studies in the 1980s and 1990s, some in animals, some in small human cohorts, looking at sleep architecture and stress hormone response, not modern controlled trials ^[2][3]. A perfectly pure, perfectly identity-confirmed peptide can still be a substance with limited human safety and efficacy data behind it. Purity tells you the vial matches the label. It tells you nothing about whether the label's promises hold up. If you want the actual research record on what DSIP has and hasn't shown in humans, that's a separate question from sourcing, and it's worth reading through before deciding on dosing at all. See dsip for the evidence rundown.

What testing methods should a legitimate lab use for DSIP?

Two methods do almost all the real work: HPLC and mass spectrometry. HPLC (high-performance liquid chromatography) separates the sample into components based on how they move through a column, then measures the relative amount of each. The result is usually expressed as a percentage of total peak area attributed to the main compound. This is the standard purity method across peptide manufacturing and pharmaceutical analysis generally, and it's the same underlying separation technique described in USP General Chapter <621> Chromatography, the reference method pharmaceutical labs cite when they validate an HPLC purity assay ^[4]. Mass spectrometry (MS) measures the mass-to-charge ratio of ionized molecules, confirming the molecular weight matches what DSIP should weigh, with a reference molecular weight for DSIP of about 849 Da listed in PubChem's compound record ^[5]. This is identity confirmation, separate from purity. A COA that reports only HPLC purity with no MS identity check has a hole in it: you know something is 98% pure, you don't know that something is DSIP. Some higher-end COAs also include amino acid analysis (confirming the actual sequence, more than the mass) and testing for endotoxins, especially relevant for anything intended for injection. These are less standard in the peptide research market and their absence isn't automatically disqualifying, but their presence is a good sign of a lab doing real work rather than a minimum-viable report.

Why do different DSIP sellers report different purity numbers?

Purity numbers vary batch to batch even from the same manufacturer, because synthesis runs aren't perfectly identical. A seller reporting 98.2% on one lot and 99.4% on the next isn't necessarily lying, that's normal batch variance in peptide synthesis. What should raise an eyebrow is when every batch, from every supplier, across a multi-year period, reports the exact same number down to a decimal point. Real analytical chemistry has noise. Identical results across dozens of theoretically independent tests suggest either a template PDF or a lab that isn't running a fresh sample each time. It's also worth noting that a slightly lower purity number from a lab that shows its methodology, lot-matching, and contact information is more trustworthy than a suspiciously perfect number from an anonymous PDF. The number alone, divorced from documentation, tells you almost nothing.

Should I trust a COA the seller provides, or ask for independent testing?

Seller-provided COAs are the norm in this market, and treating all of them as worthless would make sourcing impossible. But there's a real difference between a seller who commissions testing from an independent, named lab and posts the actual report, versus one who writes their own purity number into a template. The strongest signal is a COA from a lab you can independently verify (search the lab's name, confirm it exists, confirms it does third-party contract testing) with a batch number matching your product, and (ideally) enough transparency that you could theoretically send your own sample to the same lab for comparison. Some buyers who use meaningful amounts of research peptides do send samples out for independent third-party verification themselves. That costs real money (analytical testing runs commonly cost on the order of $50 to $150+ per sample depending on the panel), and it's not something most individual buyers will do for a single vial. For most people, the realistic move is: check the COA carefully using the criteria above, buy from a source that has a consistent, verifiable testing history, and treat purity claims as directional rather than certified.

What does the DSIP COA NOT tell you?

This is the section most marketing conveniently skips. A COA does not tell you the product is sterile. Sterility testing is a separate, specific test and most research-peptide COAs don't include it. A COA does not tell you the product is safe at any given dose. Dosing information for DSIP is thin and largely extrapolated from small older studies, not established clinical dosing guidance. If you're trying to figure out how much to use, that's a separate conversation from purity, covered at dsip dosage and, for people who want to run the math on a specific vial concentration, the dsip dosage calculator. A COA does not tell you how to reconstitute or inject the peptide correctly. Improper reconstitution or injection technique introduces its own risks independent of peptide purity, covered separately at dsip peptide injection. A COA does not tell you about side effects or interactions. That's a distinct safety question, addressed at dsip peptide side effects, and it doesn't change based on how pure the vial is. Finally, a COA does not make the product legal for human use, doesn't establish efficacy, and doesn't substitute for medical supervision. It answers one narrow question: is this substance, in this vial, roughly what the label claims. That's useful and worth checking. It's not the same as safety or efficacy evidence.

How does DSIP's COA situation compare to other research peptides?

DSIP isn't unusual here. Nearly the entire unregulated research-peptide market (BPC-157, thymosin beta-4, various growth hormone secretagogues) runs on the same seller-provided COA model with the same verification problems. What sets DSIP apart is how old and thin its underlying human research is relative to how confidently it's marketed for sleep. The name itself, delta sleep-inducing peptide, comes from research in animals (originally rabbits) in the 1970s showing an association with delta-wave sleep activity ^[2]. Human studies that followed, mostly small, some open-label, some in specific populations like alcohol-dependent patients or people with stress-related complaints, showed mixed and modest signals, not a clean, replicated sleep-improvement result ^[3]. That's a fundamentally different situation from a peptide with a large modern trial base. A perfect COA on DSIP still sits on top of a genuinely old and limited evidence pyramid. Buyers sometimes conflate "the vial is pure" with "the compound is proven," and those are separate claims that need separate evidence.

What should I actually do before buying DSIP based on its COA?

Practically, here's the checklist that matters more than any single purity number: 1. Confirm the COA has a lot number matching your product, not a generic or reused one. 2. Confirm the testing lab is a real, named, independently searchable entity. 3. Confirm the COA includes mass spec identity confirmation, more than an HPLC purity percentage. 4. Confirm the analysis date is reasonably recent relative to when the batch was produced. 5. Be skeptical of round, suspiciously perfect numbers repeated across many products and years. 6. Understand that even a flawless COA only confirms identity and purity, not sterility, safety, dosing, or efficacy. For sourcing specifically, going through a provider-reviewed route where a licensed pharmacy partner is named and fulfillment is traceable removes a lot of the guesswork that independent COA-reading is trying to solve in the first place. Buy DSIP walks through what that looks like in practice, including how DSIP Peptide's provider-reviewed listings connect to a named fulfilling pharmacy rather than an anonymous vial-and-PDF seller.

Frequently asked questions

What is a certificate of analysis for a peptide like DSIP?

A certificate of analysis (COA) is a lab report for one specific production batch, confirming identity (usually via mass spectrometry) and purity (usually via HPLC). It's the main quality document buyers get for research peptides sold outside FDA-regulated drug channels, since DSIP has no approved New Drug Application under 21 U.S.C. § 355 ^[1].

What purity percentage should a DSIP COA show?

Most sellers report purity in the high 90s, commonly 98% or higher, using HPLC. There's no official minimum standard for research-market peptides, so the number alone matters less than whether it's tied to a verifiable lab, a matching lot number, and a recent test date.

Can a DSIP COA be faked or reused across batches?

Yes, this is the most common quality problem. Sellers sometimes attach the same COA PDF to every batch sold over months or years. Check that the lot number on the document matches your vial and that the analysis date makes sense relative to when the batch was actually produced.

Does mass spectrometry or HPLC matter more on a COA?

They answer different questions. HPLC measures purity (what fraction of the sample is the target compound). Mass spectrometry confirms identity (that the molecule's mass matches DSIP's expected weight). A COA with only HPLC purity and no MS identity check is incomplete.

Is DSIP legal to buy and use in the United States?

DSIP has no FDA-approved New Drug Application and is not lawfully marketed for human use under 21 U.S.C. § 355. It's typically sold labeled 'for research use only.' A high-quality COA doesn't change its regulatory status; it only speaks to what's physically in the vial ^[1].

Does a good COA mean DSIP will actually help with sleep?

No. A COA confirms identity and purity, not efficacy. DSIP's human sleep evidence comes mostly from small studies in the 1980s-90s with mixed results, not large modern trials ^[3]. Purity and proof of effect are separate questions entirely.

How much does independent third-party peptide testing cost?

Sending a sample to an independent analytical lab for purity and identity testing commonly runs somewhere in the range of $50 to $150 or more per sample, depending on the panel requested (HPLC purity alone versus HPLC plus mass spec plus additional screens). Most individual buyers don't do this themselves.

What's the difference between a COA and a safety certification?

A COA addresses identity and purity of one batch. It does not address sterility, endotoxin levels, heavy metals, or human safety at any dose. Those require separate specific tests (like sterility or bacterial endotoxin assays) that most research-peptide COAs don't include.

Why do DSIP purity numbers vary between sellers?

Some variance (like 98.2% versus 99.4%) is normal batch-to-batch noise in peptide synthesis. What's suspicious is identical numbers, down to the decimal, repeated across every batch and every year from the same seller, which suggests a copy-pasted template rather than fresh testing.

Where does the name 'delta sleep-inducing peptide' come from?

The name comes from research starting in the 1970s in animals (originally rabbits) associating the peptide with delta-wave brain activity during sleep. It's a legacy name from that early animal research, not a certification that human sleep benefits are established ^[2].

Should I buy DSIP from a source with no COA at all?

No. A missing COA means there's zero third-party evidence of what's in the vial. Even an imperfect COA (as long as it has a matching lot number and a real lab name) is better than nothing, but a listing with no analytical documentation at all is a hard pass.

Does the COA tell me how to dose or inject DSIP?

No, a COA covers identity and purity only. Reconstitution, dosing, and injection technique are separate topics with their own considerations, and DSIP dosing guidance is itself limited by thin human trial data rather than established clinical protocols.

Sources

1. 21 U.S.C. § 355, Federal Food, Drug, and Cosmetic Act (New Drug Approval): DSIP has no FDA-approved New Drug Application and is not lawfully marketed for human use in the United States
2. 21 U.S.C. § 353b, Federal Food, Drug, and Cosmetic Act (Outsourcing Facilities/Compounding): Federal compounding law sets conditions for lawful compounding of unapproved bulk drug substances, conditions research-use peptide sellers generally do not operate under
3. Schoenenberger & Monnier, PNAS (1977): Original identification and naming of delta sleep-inducing peptide from animal research
4. Graf & Kastin, Peptides (1986) review: Review of DSIP human and animal study findings showing mixed, limited results
5. USP General Chapter <621> Chromatography, United States Pharmacopeia: HPLC is a standard reference method for chromatographic purity assessment in pharmaceutical analysis
6. PubChem Compound Summary, Delta Sleep-Inducing Peptide (CID 68962): DSIP's expected molecular weight of approximately 849 Da used as the mass spec identity reference point